Mark Merritt, President & Chief Executive Officer, PCMA
Steve Miller, Senior Vice President & Chief Medical Officer, Express Scripts Jon Roberts, President, CVS/caremark & Executive Vice President, CVS Health
Dave Ricks, Senior Vice President & President, Lilly Bio-Medicines, Eli Lilly and Company
Jim Robinson, President, Astellas Pharma US, Inc.
Mark Thierer, Chief Executive Officer, OptumRx
Moderator: Susan Dentzer, Senior Policy Advisor, Robert Wood Johnson Foundation
Discussions around a sustainable health care model are becoming more and more prevalent amongst industry insiders, economists, policy makers, and consumers alike. This panel brings together leaders from the pharmaceutical manufacturer and PBM industries to discuss their shared interests in brining innovative products to market that address unmet medical needs in the most effective and affordable way for the system.
During this session, the panel will discuss industry strategies, market trends, and collaboration opportunities. Discussion topics will include:
- The importance of data and its role in defining value;
- Biosimilars and their role in an open and competitive marketplace;
- International pricing models, international drug approvals, and international patient data; and
- 21st Century Cures and other industry regulatory challenges and opportunities.